Table 4.

Distribution of coronavirus disease 2019 treatment

TreatmentTotal, N=3213, n (%)Severe Acute Respiratory Syndrome Coronavirus 2 PositiveP value
Kidney Transplant Recipients, N=32, n (%)Non-Kidney Transplant Recipients, N=3181, n (%)
Hydroxychloroquine2136 (66)27 (84)2109 (66)0.03
Tocilizumab1275 (40)21 (66)1254 (39)0.003
Methylprednisolone611 (19)10 (31)601 (19)0.08
Remdesivir309 (10)2 (6)307 (10)0.52
Azithromycin618 (19)6 (19)612 (19)0.94
  • P values were obtained using the Kruskal-Wallis test. Values in red represent statistically significant differences. Fisher’s exact test was used for comparison in cells with < five participants.